Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: Structural features and biological properties

Journal of Biological Chemistry

Volumn 288, Issue 36, 2013, Pages 25895-25907

  Viskov, Christian ^b   Elli, Stefano ^a   Urso, Elena ^a   Gaudesi, Davide ^a,d   Mourier, Pierre ^b   Herman, Frederic ^b   Boudier, Christian ^c   Casu, Benito ^a   Torri, Giangiacomo ^a   Guerrini, Marco ^a  

^a Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

^b SANOFI   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d DULBECCO TELETHON INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BIOLOGICAL PROPERTIES; MOLECULAR ASSEMBLY; PENTASACCHARIDES; STRUCTURAL FEATURE; SULFATED POLYSACCHARIDES;

BIOCHEMISTRY; BIOLOGY;

POLYSACCHARIDES;

ANTITHROMBIN; CARBOHYDRATE; ENOXAPARIN; FONDAPARINUX; HEPARIN DODECASACCHARIDE; LOW MOLECULAR WEIGHT HEPARIN; PENTASACCHARIDE; SEMULOPARIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOHYDRATE ANALYSIS; DEPOLYMERIZATION; FLUORESCENCE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEPARATION TECHNIQUE;

3-O-SULFATION; ANTITHROMBIN; GLYCOSAMINOGLYCAN; HEPARIN; MASS SPECTROMETRY (MS); NMR;

CARBOHYDRATE SEQUENCE; FACTOR XA; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OLIGOSACCHARIDES;

EID: 84883679862     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.485268     Document Type: Article

References (32)

1. Barowcliffe, T. W. (2012) in Heparin: A Century of Progress (Lever, R., Mulloy, B., and Page, C. P., eds) pp. 3-22, Springer-Verlag, Berlin
2. Lever, R., and Page, C. P. (2012) Heparin: A Century of Progress (Lever, R., Mulloy, B., and Page, C. P., eds) pp. 281-306, Springer-Verlag, Berlin
3. Thunberg, L., Bäckström, G., and Lindahl, U. (1982) Further characterization of the antithrombin-binding sequence in heparin. Carbohydr. Res. 100, 393-410
4. Jeske, W., Lormeau, J. C., Callas, D., Iqbal, O., Hoppensteadt, D., and Fareed, J. (1995) Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins. Semin. Thromb. Hemost. 21, 193-200
5. Petitou, M., and van Boeckel, C. A. (2004) A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? Angew. Chem. Int. Ed. Engl. 43, 3118-3133
6. Casu, B. (2005) in Chemistry and Biology of Heparin and Heparan Sulfate (Garg, H. G., Linhardt, R. J., and Hales, C. A., eds) pp. 1-28, Elsevier, Oxford
7. Wlad, H., Maccarana, M., Eriksson, I., Kjellén, L., and Lindahl, U. (1994) Biosynthesis of heparin. Different molecular forms ofO-sulfotransferases. J. Biol. Chem. 269, 24538-24541
8. Kusche, M., Bäckström, G., Riesenfeld, J., Petitou, M., Choay, J., and Lindahl, U. (1988) Biosynthesis of heparin. O-Sulfation of the antithrombinbinding region. J. Biol. Chem. 263, 15474-15484
9. Shworak, N. W., Liu, J., Petros, L. M., Zhang, L., Kobayashi, M., Copeland, N. G., Jenkins, N. A., and Rosenberg, R. D. (1999) Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cDNAs and identification of distinct genomic loci. J. Biol. Chem. 274, 5170-5184
10. Jordan, R. E., Favreau, L. V., Braswell, E. H., and Rosenberg, R. D. (1982) Heparin with two binding sites for antithrombin or platelet factor
11. Bisio, A., Vecchietti, D., Citterio, L., Guerrini, M., Raman, R., Bertini, S., Eisele, G., Naggi, A., Sasisekharan, R., and Torri, G. (2009) Structural features of low molecular weight heparins affecting their affinity to antithrombin. Thromb. Haemost. 102, 865-873
12. Toida, T., Hileman, R. E., Smith, A. E., Vlahova, P. I., and Linhardt, R. J. (1996) Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites. J. Biol. Chem. 271, 32040-32047
13. Mourier, P. A., and Viskov, C. (2004) Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases. Anal. Biochem. 332, 299-313
14. Guerrini, M., Guglieri, S., Beccati, D., Torri, G., Viskov, C., and Mourier, P. (2006) Conformational transitions induced in heparin oligosaccharides by binding with antithrombin III. Biochem. J. 399, 191-198
15. Guerrini, M., Guglieri, S., Casu, B., Torri, G., Mourier, P., Boudier, C., and Viskov, C. (2008) Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue. J. Biol. Chem. 283, 26662-26675
16. Guerrini, M., Elli, S., Gaudesi, D., Torri, G., Casu, B., Mourier, P., Herman, F., Boudier, C., Lorenz, M., and Viskov, C. (2010) Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin. J. Med. Chem. 53, 8030-8040
17. Guerrini, M., Elli, S., Mourier, P., Rudd, T. R., Gaudesi, D., Casu, B., Boudier, C., Torri, G., and Viskov, C. (2013) An unusual antithrombinbinding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence. Biochem. J. 449, 343-351
18. Gray, E., Mulloy, B., and Barrowcliffe, T. W. (2008) Heparin and lowmolecular- weight heparin. Thromb. Haemost. 99, 807-818
19. Viskov, C., Just, M., Laux, V., Mourier, P., and Lorenz, M. (2009) Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026. J. Thromb. Haemost. 7, 1143-1151
20. Lima, M. A., Viskov, C., Herman, F., Gray, A. L., de Farias, E. H., Cavalheiro, R. P., Sassaki, G. L., Hoppensteadt, D., Fareed, J., and Nader, H. B. (2013) Ultra-low-molecular-weight heparins: Precise structural features impacting specific anticoagulant activities. Thromb. Haemost. 109, 471-478
21. Mourier, P., and Viskov, C. (October 18, 2012) Polysaccharides Comprising Two Antithrombin III-binding Sites, Preparation Thereof and Use Thereof as Antithrombotic Medicaments. Patent WO 2012/140580 A1
22. Biberovic, V., Grondard, L., Mourier, P., and Viskov, C. (August 23, 2011) Mixture of sulfated oligosaccharides. U. S. Patent 8,003,623 B2
23. Ferro, D. R., Provasoli, A., Ragazzi, M., Torri, G., Casu, B., Gatti, G., Jacquinet, J. C., Sinay, P., Petitou, M., and Choay, J. (1986) Evidence for conformational equilibrium of the sulfated L-iduronate residue in heparin and in synthetic heparin mono- and oligosaccharides: NMR and forcefield studies. J. Am. Chem. Soc. 108, 6773-6778
24. Hricovíni, M., Guerrini, M., Bisio, A., Torri, G., Petitou, M., and Casu, B. (2001) Conformation of heparin pentasaccharide bound to antithrombin III. Biochem. J. 359, 265-272
25. Casu, B., and Lindahl, U. (2001) Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 57, 159-206
26. Rosenfeld, L., and Danishefsky, I. (1988) Location of specific oligosaccharides in heparin in terms of their distance from the protein linkage region in the native proteoglycan. J. Biol. Chem. 263, 262-266
27. Pejler, G., Danielsson, A., Björk, I., Lindahl, U., Nader, H. B., and Dietrich, C. P. (1987) Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. J. Biol. Chem. 262, 11413-11421
28. Horner, A. A., Kusche, M., Lindahl, U., and Peterson, C. B. (1988) Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin. Biochem. J. 251, 141-145
29. Shriver, Z., Sundaram, M., Venkataraman, G., Fareed, J., Linhardt, R., Biemann, K., and Sasisekharan, R. (2000) Cleavage of the antithrombin IIIbinding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. Proc. Natl. Acad. Sci. U.S.A. 97, 10365-10370
30. DiGabriele, A. D., Lax, I., Chen, D. I., Svahn, C. M., Jaye, M., Schlessinger, J., and Hendrickson, W. A. (1998) Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 393, 812-817
31. Lindahl, U., Feingold, D. S., and Rodén, L. (1986) Biosynthesis of heparin. Trends Biochem. Sci. 11, 221-225
32. Moon, A. F., Xu, Y., Woody, S. M., Krahn, J. M., Linhardt, R. J., Liu, J., and Pedersen, L. C. (2012) Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin. Proc. Natl. Acad. Sci. U.S.A. 109, 5265-5270